Related references
Note: Only part of the references are listed.Phase I/II trial of formoterol fumarate combined with megestrol acetate in cachectic patients with advanced malignancy
C. A. Greig et al.
SUPPORTIVE CARE IN CANCER (2014)
Beclomethasone dipropionate and formoterol reduce oxidative/nitrosative stress generated by cigarette smoke extracts and IL-17A in human bronchial epithelial cells
Angela Marina Montalbano et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
The xanthine oxidase inhibitor oxypurinol reduces cancer cachexia-induced cardiomyopathy
Jochen Springer et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Myocardial dysfunction in an animal model of cancer cachexia
Hui Xu et al.
LIFE SCIENCES (2011)
No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure
Yoshihiro J. Akashi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2009)
Novel approaches to the treatment of cachexia
Josep M. Argiles et al.
DRUG DISCOVERY TODAY (2008)
Anticachectic effects of formoterol:: A drug for potential treatment of muscle wasting
S Busquets et al.
CANCER RESEARCH (2004)
Cancer cachexia:: the molecular mechanisms
JM Argilés et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
Subtype specific roles of β-adrenergic receptors in apoptosis of adult rat ventricular myocytes
Y Shizukuda et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2002)
Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the β2-adrenergic receptor
RT Hinkle et al.
MUSCLE & NERVE (2002)
Muscle-specific effects of hindlimb suspension and clenbuterol in mature male rats
LE Wineski et al.
CELLS TISSUES ORGANS (2002)
Share Paper
